Lv6
1660 积分 2022-04-15 加入
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management
16小时前
已完结
Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the US
8天前
已完结
Changes in the Dynamic Trajectory of Remnant Cholesterol Affect the Occurrence of Nonalcoholic Fatty Liver Disease
15天前
已完结
Development and validation of a nomogram to estimate future risk of type 2 diabetes mellitus in adults with metabolic syndrome: prospective cohort study
16天前
已完结
Synergistic Impact of Sarcopenia and T2DM on Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD )
23天前
已完结
Sarcopenia and MASLD: novel insights and the future
23天前
已完结
Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
28天前
已完结
Coffee and Tea Intake, Dementia Risk, and Cognitive Function
1个月前
已完结
Revisiting the obesity paradox in MASLD: longitudinal trajectory analysis reveals time-varying mortality risks
1个月前
已完结
Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
1个月前
已完结
皖公网安备34019202002308
